Kenvue Inc. (NYSE: KVUE)

Kenvue is the world’s largest pure-play consumer health company by revenue, specializing in everyday care products that bridge healthcare and consumer goods. The company operates at the intersection of science and consumer insights, delivering trusted brands that empower individuals to maintain and improve their health. With a portfolio of iconic names such as Aveeno, BAND-AID, Johnson’s, Listerine, Neutrogena, Nicorette, Tylenol, and Zyrtec, Kenvue combines scientific innovation with digital strategies to create products that are recommended by healthcare professionals and integrated into daily routines. The company markets its offerings in over 165 countries, leveraging a global footprint to address diverse consumer needs across self-care, skin health, beauty, and essential health categories.

Kenvue generates revenue through the sale of over-the-counter medicines, personal care products, and health-related solutions. Its primary products include pain relievers, allergy medications, oral care items, baby care essentials, wound care supplies, and dermatological skincare solutions. The company distributes its products through retail channels, e-commerce platforms, and direct-to-consumer initiatives, catering to both individual consumers and healthcare professionals. In the fiscal year 2025, Kenvue reported $15.1 billion in net sales, reflecting its strong market presence and broad product portfolio.

The company operates through the following segments:

• Self Care: This segment focuses on over-the-counter healthcare solutions, including cough, cold, and allergy remedies, pain care products, digestive health aids, smoking cessation tools, and eye care items. Key brands in this segment include Tylenol, Zyrtec, Benadryl, Motrin, Nicorette, and Zarbee’s. The segment also integrates digital diagnostics and telemedicine to provide personalized health offerings, enhancing accessibility and consumer engagement.

• Skin Health and Beauty: This segment encompasses face and body care, hair care, sun protection, and other beauty products. Leading brands such as Neutrogena, Aveeno, OGX, Rogaine, and Dr. Ci:Labo leverage scientific expertise and partnerships with dermatologists to deliver dermatological solutions. The segment emphasizes innovation and professional endorsements to drive consumer trust and loyalty.

• Essential Health: This segment includes oral care, baby care, wound care, and women’s health products. Major brands like Listerine, Johnson’s, BAND-AID, Desitin, and o.b. tampons address fundamental personal care needs. The segment focuses on raising standards in categories such as menstrual health, oral hygiene, and infant care, ensuring broad accessibility and reliability.

Kenvue holds a dominant position in the global consumer health industry, competing with established consumer packaged goods companies, pharmaceutical groups, and niche brands. Its key competitors include Haleon, Procter & Gamble, Reckitt Benckiser Group, Unilever, Beiersdorf, Estée Lauder, L’Oréal, Church & Dwight, Colgate-Palmolive, and Kimberly-Clark. The company’s competitive advantages stem from its extensive portfolio of science-backed, trusted brands, deep consumer insights, and digital marketing capabilities. Kenvue’s focus on innovation, coupled with its global scale and strong relationships with healthcare professionals, enables it to maintain leadership in highly competitive markets. Additionally, its commitment to sustainability and corporate governance further strengthens its industry standing.

Kenvue serves a diverse customer base spanning individual consumers, healthcare professionals, and retail partners worldwide. Its products are distributed through major retail chains, pharmacies, e-commerce platforms, and direct-to-consumer channels. The company’s brands are embedded in daily consumer routines, from baby care and oral hygiene to pain relief and skincare, making it a household name across multiple demographics and geographic regions. While specific customer names are not disclosed, Kenvue’s reach extends to millions of households, pharmacies, and healthcare providers globally.